MADISON,
Wis., Oct. 9, 2023 /PRNewswire/ -- Exact
Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer
screening and diagnostic tests, today announced that the company
plans to release its third quarter 2023 financial results after the
close of the U.S. financial markets on November 1, 2023. Following the release, company
management will host a webcast and conference call at 5 p.m. ET to discuss financial results and
business progress.
Third quarter 2023 webcast & conference call
details
Date:
|
Wednesday, November 1,
2023
|
Time:
|
5 p.m.
ET
|
Webcast:
|
The live webcast can be
accessed at www.exactsciences.com
|
Telephone:
|
Domestic callers, dial
888-330-2384
|
|
International callers,
dial +1 240-789-2701
|
|
Access code for both
domestic and international callers: 4437608
|
An archive of the webcast will be available at
www.exactsciences.com. A replay of the conference call will be
available by calling 800-770-2030 domestically or +1 647-362-9199
internationally. The access code for the replay of the call is
4437608. The webcast, conference call, and replay are open to all
interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences gives patients and health care professionals the
clarity needed to take life-changing action earlier. Building on
the success of the Cologuard® and Oncotype® tests, Exact Sciences
is investing in its pipeline to develop innovative solutions for
use before, during, and after a cancer diagnosis. For more
information, visit ExactSciences.com, follow Exact Sciences on
Twitter @ExactSciences, or find Exact Sciences on LinkedIn and
Facebook.
Contact:
Megan
Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download
multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-third-quarter-2023-earnings-call-301949871.html
SOURCE Exact Sciences Corporation